Sequencing Therapy for Metastatic Triple Negative Breast Cancer

Kevin Kalinsky MD MS is an associate professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine. He discussed how to best sequence antibody drug conjugates in patients with triple negative breast cancer. The biggest advance recently has been the addition of trust use of Mab du Rux T-Can for patients with her too low metastatic breast cancer.